Luye Pharma is a leading Chinese specialty pharmaceutical company focusing on drug-delivery systems. The Company engages in the development, manufacturing and sale of patented prescription medicines in oncology, cardiovascular, orthopedics, neurology and gastrointestinal fields. Its six main products command either No. 1 or No. 2 market positions in their respective target segments. The Company was sold to a consortium of private equity firms, CITIC PE, CDH and New Horizon in February 2012.